F Cay
Overview
Explore the profile of F Cay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cay F, Arat A
AJNR Am J Neuroradiol
. 2022 Jul;
43(8):1152-1157.
PMID: 35902123
Background And Purpose: Stent bulging technique has been introduced as a technique that improves the outcome of aneurysm coiling. Our aim was to evaluate the utility of this technique, which...
2.
Aydin K, Berdikhojayev M, Cay F, Barburoglu M, Nurzhan S, Aygun S, et al.
AJNR Am J Neuroradiol
. 2022 Mar;
43(4):560-567.
PMID: 35301223
Background And Purpose: Most distal MCA aneurysms are located within the insular segment, which lies between the limen insulae and circular sulcus. However, experience is limited in the microsurgical and...
3.
Cay F, Cil B, Balci S, Arsava E, Topcuoglu M, Arat A
AJNR Am J Neuroradiol
. 2020 Jun;
41(6):1054-1060.
PMID: 32499248
Background And Purpose: Carotid near-occlusion has been subclassified into near-occlusion with and without collapse. We aimed to compare the technical success and perioperative complication rates of carotid artery stent placement...
4.
Icli F, Akbulut H, Dincol D, Onur H, Demirkazik A, Cam R, et al.
Ann Oncol
. 2001 Aug;
12(7):1011-3.
PMID: 11521785
Background: Four cycles of AC have been accepted as the standard chemotherapy in breast cancer. In the present randomized study we aimed to assess the efficacy of adjuvant etoposide +...
5.
Arican A, Dincol D, Akbulut H, Onur H, Demirkazik A, Cay F, et al.
Am J Clin Oncol
. 1999 Dec;
22(6):587-92.
PMID: 10597743
Clinical, histopathologic, and prognostic features of 114 patients with primary extranodal non-Hodgkin's lymphoma were evaluated. Median age of the patients was 48 (range, 15-76) and the ratio of male/female was...
6.
Icli F, Arican A, Cay F, Akbulut H, Dincol D, Karaoguz H, et al.
Oncology
. 1999 May;
56(4):297-300.
PMID: 10343193
Twenty-six patients with metastatic colorectal cancer were given cisplatin (CDDP) and dacarbazine (DTIC). Patients who relapsed while receiving adjuvant 5-fluorouracil (FU) or had 5-FU-resistant metastatic disease were included. Median age...
7.
Demirkazik A, Dincol D, Hasturk S, Arican A, Karaoguz H, Cay F, et al.
Cancer Biochem Biophys
. 1999 Mar;
16(3):243-51.
PMID: 10072208
Unlabelled: The diagnostic value of ferritin in pleural effusions or ascites was studied in 151 samples from 147 patients (four patients had both kind of effusions). Samples (99 pleural effusions,...
8.
Dincol D, Akbulut H, Icli F, Samur M, Karaoguz H, Demirkazik A, et al.
Oncology
. 1997 Sep;
54(5):376-9.
PMID: 9260598
Prognostic factors and the results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +/- bleomycin treatment in 93 consecutive evaluable patients with aggressive lymphomas are presented. The overall response rate, excluding...
9.
Icli F, Karaoguz H, Akbulut H, Dincol D, Demirkazik A, Cay F
J Surg Oncol
. 1997 Apr;
64(4):318-23.
PMID: 9142190
Background: Based on the promising results of EAP (etoposide, doxorubicin, and cisplatin) combination, a phase II study of modified EAP combination was performed in patients with advanced gastric cancer to...
10.
Icli F, Karaoguz H, Hasturk S, Kurt B, Akbulut H, Dincol D, et al.
Lung Cancer
. 1996 Sep;
15(2):207-13.
PMID: 8882987
Thirty-one consecutive patients with histologically proven and symptomatic malignant mesothelioma were treated with two dose levels of ifosfamide. The first group of 15 patients were given 2.3 g/m2/day for 5...